On the recordAugust 5, 2026
If we cede global biotechnology leadership to China, we risk a future where high-skilled biotech jobs migrate abroad, first-in-class therapies do not reach American patients first, and pharmaceutical supply chains are strategically weaponized.
Source
young.senate.gov




